DK54879A - Fremgangsmaade til fremstilling af pyrimidoner - Google Patents
Fremgangsmaade til fremstilling af pyrimidonerInfo
- Publication number
- DK54879A DK54879A DK54879A DK54879A DK54879A DK 54879 A DK54879 A DK 54879A DK 54879 A DK54879 A DK 54879A DK 54879 A DK54879 A DK 54879A DK 54879 A DK54879 A DK 54879A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrimidones
- preparing
- procedure
- preparing pyrimidones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB574078 | 1978-02-13 | ||
GB2283478 | 1978-05-25 | ||
GB7844259 | 1978-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK54879A true DK54879A (da) | 1979-08-14 |
Family
ID=27254696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK54879A DK54879A (da) | 1978-02-13 | 1979-02-09 | Fremgangsmaade til fremstilling af pyrimidoner |
Country Status (31)
Country | Link |
---|---|
US (2) | US4234588A (ko) |
EP (1) | EP0003677B1 (ko) |
JP (1) | JPS54115385A (ko) |
AR (1) | AR223476A1 (ko) |
AT (1) | AT372087B (ko) |
AU (1) | AU531757B2 (ko) |
BG (1) | BG34906A3 (ko) |
CA (1) | CA1147335A (ko) |
DD (1) | DD142052A5 (ko) |
DE (1) | DE2961289D1 (ko) |
DK (1) | DK54879A (ko) |
EG (1) | EG13747A (ko) |
ES (1) | ES477667A1 (ko) |
FI (1) | FI66000C (ko) |
HK (1) | HK15487A (ko) |
HU (1) | HU180945B (ko) |
IE (1) | IE48313B1 (ko) |
IL (1) | IL56611A (ko) |
IN (1) | IN151188B (ko) |
IT (1) | IT1119272B (ko) |
MX (1) | MX5926E (ko) |
MY (1) | MY8500590A (ko) |
NO (1) | NO151546C (ko) |
NZ (1) | NZ189592A (ko) |
PH (2) | PH18073A (ko) |
PL (1) | PL118708B1 (ko) |
PT (1) | PT69203A (ko) |
RO (1) | RO83454A (ko) |
SG (1) | SG61782G (ko) |
SU (1) | SU999971A3 (ko) |
YU (1) | YU29279A (ko) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4584384A (en) * | 1978-05-30 | 1986-04-22 | Smith Kline & French Laboratories Limited | Nitro pyrroles |
IL57415A (en) * | 1978-05-30 | 1984-08-31 | Smith Kline French Lab | Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them |
ZA793392B (en) * | 1978-07-15 | 1980-08-27 | Smith Kline French Lab | Isoureas and isothioureas |
ZA793443B (en) * | 1978-07-26 | 1980-12-31 | Glaxo Group Ltd | Heterocyclic derivatives |
YU53681A (en) * | 1980-03-08 | 1983-12-31 | Smith Kline French Lab | Process for obtaining 5-dimethylamino-methyl-2-furane methanol |
CA1155842A (en) * | 1980-03-29 | 1983-10-25 | Thomas H. Brown | Compounds |
US4439609A (en) * | 1980-10-01 | 1984-03-27 | Smith Kline & French Laboratories Limited | Pyridines |
ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
US4352933A (en) * | 1981-02-06 | 1982-10-05 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
US4439437A (en) * | 1981-04-28 | 1984-03-27 | Smith Kline & French Laboratories Limited | 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use |
ZA823149B (en) * | 1981-05-27 | 1983-03-30 | Smithkline Beckman Corp | Chemical process |
IE53193B1 (en) * | 1981-07-14 | 1988-08-17 | Smithkline Beckman Corp | Preparation of lower alkyl 2-formyl-3-(6-methyl-3-pyridinyl)-propionates |
WO1983002113A1 (en) * | 1981-12-17 | 1983-06-23 | Yuki, Hiroshi | Propenylamine derivatives and drug containing same |
CA1211111A (en) * | 1982-02-15 | 1986-09-09 | Isao Yanagisawa | Process for preparing novel pyrimidone compounds |
US4808589A (en) * | 1982-02-20 | 1989-02-28 | Smith Kline & French Laboratories Limited | Pyrimidone derivatives |
EP0103366B1 (en) * | 1982-07-20 | 1986-02-19 | Smith Kline & French Laboratories Limited | A process for the preparation of 2-(2-((5-dimethyl-aminomethyl)furan-2-ylmethylthio)ethylamino)-5-(6-methylpyrid-3-ylmethyl)pyrimid-4-one |
DE3365869D1 (en) * | 1982-07-30 | 1986-10-09 | Smith Kline French Lab | Amino pyrimidinones and their preparation |
GB8304593D0 (en) * | 1983-02-18 | 1983-03-23 | Beecham Group Plc | Amidines |
GB8311443D0 (en) * | 1983-04-27 | 1983-06-02 | Smith Kline French Lab | Chemical compounds |
GB8318638D0 (en) * | 1983-07-09 | 1983-08-10 | Smith Kline French Lab | Chemical compounds |
GB8319874D0 (en) * | 1983-07-23 | 1983-08-24 | Smith Kline French Lab | Compounds |
GB8320505D0 (en) * | 1983-07-29 | 1983-09-01 | Smith Kline French Lab | Chemical compounds |
US4772704A (en) * | 1983-09-21 | 1988-09-20 | Bristol-Myers Company | 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity |
GB8328240D0 (en) * | 1983-10-21 | 1983-11-23 | Smith Kline French Lab | Chemical process |
GB8421427D0 (en) * | 1984-08-23 | 1984-09-26 | Smith Kline French Lab | Chemical compounds |
US4598067A (en) * | 1984-10-16 | 1986-07-01 | Biomeasure, Inc. | Antiulcer compounds |
US4785003A (en) * | 1984-10-16 | 1988-11-15 | Biomeasure, Inc. | N-disubstituted glycine and B-amino-propionic acid derivatives having anti-ulcer activity |
CH665838A5 (de) * | 1985-06-20 | 1988-06-15 | Lonza Ag | 3-hydroxy-3-(2-methyl-5-pyridyl)-propionsaeurealkylester, ihre herstellung und verwendung. |
US4912101A (en) * | 1987-03-13 | 1990-03-27 | Fujirebio Kabushiki Kaisha | 4-aminomethyl-pyridyl-2-oxy derivatives having anti-ulcer activity |
US7683069B2 (en) * | 2002-12-16 | 2010-03-23 | Mitsubishi Tanabe Pharma Corporation | 3-substituted-4-pyrimidone derivatives |
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980781A (en) * | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
GB1223686A (en) * | 1967-02-24 | 1971-03-03 | Ici Ltd | Salts of pyrimidine derivatives and the use thereof as fungicides |
GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
IN146736B (ko) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab | |
US4145546A (en) * | 1975-10-02 | 1979-03-20 | Smith Kline & French Laboratories Limited | 4-Pyrimidone compounds |
US4154834A (en) * | 1975-12-29 | 1979-05-15 | Smith Kline & French Laboratories Limited | Substituted isocytosines having histamine H2 -antagonist activity |
MW5076A1 (en) * | 1975-12-29 | 1978-02-08 | Smith Kline French Lab | Pharmacologicalle active compounds |
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
GB1601459A (en) * | 1977-05-17 | 1981-10-28 | Allen & Hanburys Ltd | Aminoalkyl thiophene derivatives |
AU527202B2 (en) * | 1978-04-11 | 1983-02-24 | Smith Kline & French Laboratories Limited | 2-aminopyrimidones |
ZA793392B (en) * | 1978-07-15 | 1980-08-27 | Smith Kline French Lab | Isoureas and isothioureas |
ZA793443B (en) * | 1978-07-26 | 1980-12-31 | Glaxo Group Ltd | Heterocyclic derivatives |
PT75074B (en) * | 1981-06-27 | 1986-02-26 | Smith Kline French Lab | Process for preparing certain pyrimidone derivatives and compositions containing them |
-
1979
- 1979-01-30 IN IN70/DEL/79A patent/IN151188B/en unknown
- 1979-02-06 AU AU43994/79A patent/AU531757B2/en not_active Ceased
- 1979-02-07 US US06/009,990 patent/US4234588A/en not_active Expired - Lifetime
- 1979-02-07 DE DE7979300190T patent/DE2961289D1/de not_active Expired
- 1979-02-07 PH PH22176A patent/PH18073A/en unknown
- 1979-02-07 NZ NZ189592A patent/NZ189592A/xx unknown
- 1979-02-07 IL IL56611A patent/IL56611A/xx unknown
- 1979-02-07 EP EP79300190A patent/EP0003677B1/en not_active Expired
- 1979-02-08 YU YU00292/79A patent/YU29279A/xx unknown
- 1979-02-08 CA CA000321100A patent/CA1147335A/en not_active Expired
- 1979-02-09 HU HU79SI1673A patent/HU180945B/hu not_active IP Right Cessation
- 1979-02-09 PT PT7969203A patent/PT69203A/pt unknown
- 1979-02-09 JP JP1488979A patent/JPS54115385A/ja active Granted
- 1979-02-09 IE IE254/79A patent/IE48313B1/en not_active IP Right Cessation
- 1979-02-09 DK DK54879A patent/DK54879A/da not_active Application Discontinuation
- 1979-02-09 FI FI790435A patent/FI66000C/fi not_active IP Right Cessation
- 1979-02-09 BG BG042428A patent/BG34906A3/xx unknown
- 1979-02-12 DD DD79210982A patent/DD142052A5/de not_active IP Right Cessation
- 1979-02-12 AT AT0104779A patent/AT372087B/de not_active IP Right Cessation
- 1979-02-12 MX MX797712U patent/MX5926E/es unknown
- 1979-02-12 NO NO790446A patent/NO151546C/no unknown
- 1979-02-12 EG EG84/79A patent/EG13747A/xx active
- 1979-02-12 PL PL1979213374A patent/PL118708B1/pl unknown
- 1979-02-12 RO RO79105057A patent/RO83454A/ro unknown
- 1979-02-12 IT IT67299/79A patent/IT1119272B/it active
- 1979-02-12 SU SU792724499A patent/SU999971A3/ru active
- 1979-02-13 AR AR275487A patent/AR223476A1/es active
- 1979-02-13 ES ES477667A patent/ES477667A1/es not_active Expired
- 1979-10-03 PH PH23104A patent/PH17517A/en unknown
-
1982
- 1982-12-07 SG SG617/82A patent/SG61782G/en unknown
-
1985
- 1985-06-21 US US06/747,496 patent/US4649141A/en not_active Expired - Lifetime
- 1985-12-30 MY MY590/85A patent/MY8500590A/xx unknown
-
1987
- 1987-02-19 HK HK154/87A patent/HK15487A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK54879A (da) | Fremgangsmaade til fremstilling af pyrimidoner | |
DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
DK149023C (da) | Analogifremgangsmaade til fremstilling af tiazolidinderivater | |
DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
DK207279A (da) | Fremgangsmaade til fremstilling af e-vitaminpulver | |
DK7579A (da) | Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid | |
DK364579A (da) | Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider | |
DK19579A (da) | Fremgangsmaade til fremstilling af spirothienohydantoinderivater | |
DK525481A (da) | Fremgangsmaade til fremstilling af pyrimidoner | |
DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
DK294880A (da) | Fremgangsmaade til fremstilling af n-phosphonomethylglycin | |
DK413780A (da) | Fremgangsmaade til fremstilling af d-6-n-propylergoliner | |
DK152138C (da) | Fremgangsmaade til fremstilling af urokinase | |
DK311779A (da) | Fremgangsmaade til fremstilling af spaanplader | |
DK138879A (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
DK161198C (da) | Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner | |
DK150479C (da) | Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin | |
DK165687C (da) | Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner | |
DK330279A (da) | Fremgangsmaade til fremstilling af soem | |
DK41079A (da) | Fremgangsmaade til masselimning af papir | |
DK177680A (da) | Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner | |
DK146628C (da) | Fremgangsmaade til fremstilling af aluminiummonoethylphosphit | |
DK196579A (da) | Fremgangsmaade til fremstilling af substituerede dibenzylethere | |
DK127179A (da) | Fremgangsmaade til fremstilling af monokaryoner | |
DK157850C (da) | Fremgangsmaade til fremstilling af 7-acylindolin-2-oner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ARF | Application refused |